Latest Articles

On September 28, 2015, the U.S. Government Accountability Office (GAO) issued a report to the Senate Committee on Health, Education, Labor and Pensions and the House Committee on Energy and Commerce on animal drug compounding. The GAO reviewed and analyzed regulation of animal drug compounding and concluded that FDA oversight could be strengthened, and recommended that executive action be taken to: (1) modify the adverse event reporting form to detect more adverse events arising…
On February 10, 2014, the Federal Circuit issued an important ruling on how patent claims are to be construed by the PTAB. The Court emphasized that its general rule that the evidence in the patent and the patent application proceedings (intrinsic evidence) outweighs other evidence (extrinsic evidence) applies not only to district court claim constructions but also to the Patent and Trademark Office (PTO).…